Nominations to the IUBMB Executive Committee

Zengyi ChangProfessor Zengyi Chang
Peking University, China (Beijing)
Nominee for President-Elect

Prof. Zengyi Chang received his Ph.D. degree in Biochemistry in 1992 from Baylor College of Medicine in USA, and then spent three years (1992-1995) as a postdoctoral fellow at the Howard Hughes Medical Institute (HHMI). In 1996, he returned to China and worked as an associate professor in the Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing, China. In 1998, he was promoted to the full professor position in Biochemistry and Molecular Biology; in 2003 he moved to Peking University, Beijing, China. He was a visiting professor of Harvard medical School (in 2002 for two months); At Peking University, he has been serving as the director of the Center of Protein Sciences since 2005 and vice dean of the School of Life Sciences between 2007 and 2013.

He has been serving as an Editor of Biochemical and Biophysical Research Communication (since 2013), an Associate Editor of Protein Science (since 2018); He also served as an editorial board member of the Journal of Biological Chemistry (for 5 years) and IUBMB Life, the executive vice Editor-in Chief of Science China Life Sciences (for 10 years). He is currently an Executive Committee member of the International Union of Biochemistry and Molecular Biology (IUBMB), He served as the President of the Federation of Asian and Oceanian Biochemists and Molecular Biologists (FAOBMB), an Executive Council member of the Protein Society (2008-2014), the president of the Asia Pacific Protein Association (APPA), vice president of the Chinese Society of Biochemistry and Molecular Biology, and President of the Chinese Protein Society, etc.

He has been conducting research in the field of protein function, mechanism and regulation, as well as the biogenesis and quality control of proteins (including ATP synthase, outer membrane proteins, molecular chaperones, etc), often in living cells. His lab is also conducting research on the molecular mechanism of dormancy (persistence) using bacteria as model organisms.

Joon KimProfessor Joon Kim
Korea University, Korea
Nominee for President-Elect

Prof. Joon KIM was born in 1957 and raised in Seoul, Korea. Until today, he has been a Professor of Biochemistry in the Division of Life Sciences of Korea University for 30 years. He is currently the President of FAOBMB until December of 2025 and the Korean delegate to the IUBMB general assembly since 2018. Prof. Kim graduated from Seoul National University with a Bachelor’s and Master’s degree in Microbiology, Seoul, Korea, and from the University of California, Berkeley, USA with a PhD degree in Biochemistry. He did his post-doctoral training in the Department of Biological Chemistry & Molecular Pharmacology at Harvard Medical School, Boston, USA.

His research has been focusing on various stress responses in yeast and human cells with emphasis on GCN4 and RPS3 proteins. Prof Kim’s research area includes stress responses, DNA repair, cancer, and ribosome biogenesis. He has supervised 41 doctoral and 86 master’s students while producing about 200 refereed papers and 20 patents. His lab is currently developing new anti-cancer and anti-fungal drugs. Through his work, he was awarded the Presidential Award, the Minister’s Award, the First Grand Academic Award from the Microbiological Society of Korea, and the First International Cooperation Award from Korea University.

For IUBMB, Prof. Kim will encourage active participation in IUBMB meetings, especially to those from neglected regions, from young scientists and female scientists by providing them with more opportunities, and he will do his best to make IUBMB an active, inspiring, and best scientific society worldwide.

Professor Sandhya VisweswariahProfessor Sandhya Visweswariah
Korea University
Nominee for President-Elect

Prof. Sandhya Visweswariah is currently an Honorary Professor at the Indian Institute of Science and a Provost’s Visiting Professor at Imperial College London, UK. She has established an internationally recognized group that investigates the biology of cyclic nucleotide signaling in eukaryotes and prokaryotes. These studies have encompassed the disciplines of biochemistry, molecular biology, and cell biology, and resulted in collaborations that have elucidated, at the structural level, molecular features of proteins involved in this signaling process. Her work has delineated the roles of various domains in the receptor for a bacterial heat-stable enterotoxin, GC-C. Working with collaborators in Europe, she characterized the first human genetic disorder contributed by mutations in GUCY2C, and mutations in GUCY2C are now recognized as contributing to inflammatory bowel disease (BD). These findings led to the award of a grant from the Bill and Melinda Gates Foundation as part of their Grand Challenges initiative to tackle diarrhoeal disease, and resulted in the generation of the first knock-in mouse model with a hyperactive mutation in Gucy2c that allowed an investigation into changes in the gut in the presence of elevated levels of cGMP. Prof. Visweswariah has made seminal contributions in identifying and characterizing enzymes involved in cyclic AMP metabolism and their role in the biology of Mycobacteria. The realization of the importance of cAMP signaling in the pathogenesis of M. tuberculosis has emerged largely due to findings from Prof. Visweswariah’s laboratory, and she is considered a leading authority on signaling in Mycobacteria.

Prof. Visweswariah is a National Science Chair, supported by the Department of Science and Technology, Government of India. She is a Fellow of The World Academy of Sciences, a Fellow of the Indian Academy of Sciences and a Fellow of the Indian National Science Academy. During her career of more than 3 decades, she received an HFSP Fellowship and was a Nehru-Fulbright Senior Fellow. She has received a Collaborative Grant for Research Professors from the Royal Society, UK, and an NIH grant in 2023. She was a Margdarshi Fellow supported by the Wellcome Trust-DBT India Alliance, and is the principal investigator in a Teams Grant also supported by them to study variants in paediatric IBD patients in India. She has reviewed papers for journals such as Nature, Science Translational Medicine, J Biological Chemistry, eLife, PLoS Genetics, J Molecular Biology and PLoS Pathogens.

In her own Institute, she was involved in establishing a programme in Bioengineering and was Co-Chair of a newly established Department of Bioengineering. She has served as the Chair of her Department, and on Committees to review several national research and academic institutions. She has engaged with collaborators nationally and internationally and is currently a Provost’s Visiting Professor at Imperial College London, UK. She has supervised more than 30 PhD students and several post-doctoral fellows who established their own research groups in academia in India and abroad. She has also been a strong advocate of fostering women in science and has mentored several women and men as they embark on scientific careers as young independent investigators. She has been invited to internationally recognised scientific meetings, including Keystone meetings on Tuberculosis, Gordon Conferences on Cyclic Nucleotides and Protein Phosphorylation and EMBO-sponsored meetings on Pseudoenzymes.

Consuelo Guerri SireraProfessor Consuelo Guerri Sirera
University of Valencia
Nominee for Executive Committee Member for Publications

Researcher and head (now Emeritus) of the Cellular Pathology Laboratory at the Fundación Valenciana Príncipe Research Center in Valencia. She has a degree in Biology and Biochemistry from the University of Valencia. From 1974-1977 she spent time in the Department of Biochemistry at the Kansas City Kansas School of Medicine, as a research associate in said department. In 1978 she defended her thesis at the University of Valencia, directed by Professor Santiago Grisolia. In 1979 she joined the Institute of Cytological Research (IIC) of Valencia as a researcher, and began her research on cellular and molecular mechanisms of the effects of alcohol during brain development and fetal alcohol syndrome. From 1984-2000 she participated as an associate research professor in the Department of Pharmacology at the University of Kansas, within the International Molecular Cytology Program. In 1980 she was appointed head of the Cellular Pathology laboratory at the IIC and in 2005 she moved to the Príncipe Felipe Research Center, where she continued to study the molecular mechanisms of the effects of alcohol during brain development and maturation (such as adolescence), and its long-term consequences. She also investigated the mechanisms by which alcohol abuse causes neuroinflammation and neurodegeneration. The ultimate goal is the development of therapies that can alleviate the irreversible damage of alcohol.

The group’s work has been recognized by different national awards and recognition (Conselleria de Sanitat, GV, 2015; Silver Medal of the Order of Merit of the National Plan on Drugs, Ministry of Health, Social Services and Equality (BOE May 13, 2016), Isabel de Villena Award, 2002) and international (Manfred Lautenschlaeger Award, Vienna 2011; Recognition “outstanding research advancing the understanding of mechanisms underlying Fetal Alcohol Syndrome and alcohol-related birth defects”, Research Society for Alcoholism and NIAAA (USA-2001) and for the invitation to different international conferences in plenary conferences (TSA, Japan, Santiago de Chile, Sao Paulo Brazil, Toronto, Seattle, Sydney, Argentina).

She has participated in the steering committee of international journals (e.g ALCOHOL, Alcoholism Clinical Experimental Research) and has participated as a founding member and a member of the Board of the European, the International and the Spanish societies for research on alcohol abuse (ESBRA, ISBRA and Sociodrogalcohol, respectively). Past member of international expert panels for evaluation of research projects both in the United States (NIH-AAA expert panel) and in Europe (French National Research Agency, Britain’s Medical Research Council, Germany).

James MurphyProfessor James Murphy
The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
Nominee for Executive Committee Member for Publications

Prof. James Murphy is the Head of the Inflammation Division at the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia. He completed his undergraduate studies in his hometown of Christchurch, New Zealand, before completing PhD studies at the Australian National University, Canberra, Australia in 2003. He completed his postdoctoral training in the lab of the signalling guru, the late Tony Pawson (Toronto, Canada) before moving to the Walter and Eliza Hall Institute. There, he pursued a mechanistic understanding of the roles of several pseudokinases, protein kinases, cytokines/receptors and epigenetic regulators in signal transduction, with a particular focus on MLKL, a key pseudokinase in the necroptosis cell death pathway. These studies have culminated in >170 publications and >12000 citations to date.

He has been an active contributor to several IUBMB member societies through conference chair (e.g. UK Biochemical Society, US ASBMB, EMBO, IUBMB) and editorial (JBC, Biochem J, Structure, TIBS, Cell Death and Differentiation) roles, and is currently Editor-in-Chief of Biochemical Society Transactions. Additionally, he is a member of the IUBMB Protein Kinase Nomenclature subcommittee. He has served as an IUBMB executive member and Chair of the IUBMB Publications committee since 2021, during which he has led to search for 3 incoming Editors-in-Chief for IUBMB journals and enacted a gender equality plan for recruitment of editors and editorial board members. He hopes to contribute further by employing his knowledge of scholastic publication as the IUBMB Publications and Nomenclature Committee Chair as an ambassador for Australasia and the Pacific region with the goal of enhancing scientific engagement with scholars globally.

Ilona Concha GrabingerProfessor Ilona Concha Grabinger
Universidad Austral de Chile, Chile
Nominee for Executive Committee Member for Congresses and Focused Meetings

Dr. Ilona Concha Grabinger is Emeritus Professor at the Universidad Austral de Chile. She obtained a Biology degree from Facultad de Ciencias, Universidad Austral de Chile in 1981. She performed her Ph.D. in Cell and Molecular Biology working on Small Nuclear RNAs in sperm cells. After finishing her Ph.D., Dr. Concha Grabinger performed several postdoctoral research stays at the Memorial Sloan Kettering Cancer Center in New York, USA. She participated in elucidating the transport system for glucose and ascorbic acid in several cell types. For years her group has been interested in the fascinating model of cell differentiation in the seminiferous tubule. In this environment, male germ cells proliferate and differentiate in close relation with Sertoli cells. She has been interested in the metabolic aspects of transport systems, facilitative hexose transporters (GLUTs) and sodium-ascorbic acid co-transporters (SVCTs), and cytokines that increase the uptake of hexose and vitamin C and thus influence proliferation, differentiation, and survival of these cells. She has also been interested in studying the physiological context of vitamin C transporters in nervous tissue. Her more recent attention has been focused on glycogen regulation in the seminiferous tubule.

She has also performed research stays at the University of Notre Dame, USA, and Universidad Autónoma de Barcelona, Spain. Over the years at the Universidad Austral de Chile, she mentored numerous undergraduate and PhD students, published original research articles in prestigious journals, presented at several national and international meetings and is member of national and international societies. She has also been actively involved in teaching as well as in academic administration duties. At the Universidad Austral de Chile she has been Vice-President, Director of Research and Development, President of the Central Commission for Academic Evaluation, Vice-Dean of the Faculty of Science and Director of the Institute of Biochemistry. She has also been President of the Chilean Society of Reproduction and Development, President of the Chilean Society of Biochemistry and Molecular Biology, Director of Biology 3 Study Group from FONDECYT, President of Biology II CONICYT Fellowships, Associate Editor of Biological Research, member of the IUBMB Fellowships Committee since 2012 and IUBMB Executive Committee Member on Congresses and Focused Meetings since 2018, among many other responsibilities.